FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-6952com.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-6952comv1
21/1/231    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patchev, A. V.
Right arrow Articles by Almeida, O. F. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patchev, A. V.
Right arrow Articles by Almeida, O. F. X.
(The FASEB Journal. 2007;21:231-238.)
© 2007 FASEB

Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice

Alexandre V. Patchev*,{dagger},1, Dieter Fischer{dagger}, Siegmund S. Wolf{ddagger}, Miles Herkenham§, Franziska Götz*, Martine Gehin||, Pierre Chambon||, Vladimir K. Patchev{ddagger} and Osborne F. X. Almeida{dagger}

* Institute of Experimental Endocrinology, Charité School of Medicine, Humboldt University, Berlin, Germany;

{dagger} Neuroadaptations Group, Max Planck Institute of Psychiatry, Munich, Germany;

{ddagger} Corporate Research Gynecology and Andrology, Schering AG, Jena, Germany;

§ Section on Functional Neuroanatomy, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA;

|| Institute de Génétique et de Biologie Moléculaire et Céllulaire (IGBMC), Illkirch, France

1Correspondence: Institute of Experimental Endocrinology, Charité School of Medicine, Humboldt University, Schumannstr. 20/21, Berlin 10117, Germany. E-mail: alexandre.patchev{at}charite.de


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The transcription-intermediary-factor-2 (TIF-2) is a coactivator of the glucocorticoid receptor (GR), and its disruption would be expected to influence glucocorticoid-mediated control of the hypothalamo-pituitary-adrenal (HPA) axis. Here, we show that its targeted deletion in mice is associated with altered expression of several glucocorticoid-dependent components of HPA regulation (e.g., corticotropin-releasing hormone, vasopressin, ACTH, glucocorticoid receptors), suggestive of hyperactivity under basal conditions. At the same time, TIF-2–/– mice display significantly lower basal corticosterone levels and a sluggish and blunted initial secretory response to brief emotional and prolonged physical stress. Subsequent analysis revealed this discrepancy to result from pronounced aberrations in the structure and function of the adrenal gland, including the cytoarchitectural organization of the zona fasciculata and basal and stress-induced expression of key elements of steroid hormone synthesis, such as the steroidogenic acute regulatory (StAR) protein and 3ß-hydroxysteroid dehydrogenase (3ß-HSD). In addition, altered expression levels of two nuclear receptors, DAX-1 and steroidogenic factor 1 (SF-1), in the adrenal cortex strengthen the view that TIF-2 deletion disrupts adrenocortical development and steroid biosynthesis. Thus, hyperactivity of the hypothalamo-pituitary unit is ascribed to insidious adrenal insufficiency and impaired glucocorticoid feedback.—Patchev, A. V., Fischer, D., Wolf, S. S., Götz, F., Gehin, M., Chambon, P., Patchev, V. K., and Almeida O. F. X. Insidious adrenocortical insufficiency underlies neuroendocrine dysregulation in TIF-2 deficient mice.


Key Words: stress • adrenal cortex • steroidogenesis • hypothalamus • hippocampus


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
STRESSORS EVOKE NEUROHUMORAL responses within the hypothalamic-pituitary-adrenal (HPA) axis, the magnitude and duration of which reliably describe the organism’s adaptive potential. Chronic stress and glucocorticoid hypersecretion can eventually lead to pathological states (1 , 2) . Curtailment of the endocrine response to stress is executed by glucocorticoid receptor (GR)-mediated negative feedback mechanisms in the hippocampus, hypothalamus, and pituitary, manifested as reduced synthesis and secretion of pituitary ACTH and its hypothalamic secretagogues, corticotropin-releasing hormone (CRH), and vasopressin (AVP) (1 2 3) .

GR signaling efficacy is determined by a variety of coactivators, including the transcription intermediary factor 2 (TIF-2/SRC-2/NCoA2/GRIP1). TIF-2 belongs to the p160 family of cellular proteins (e.g., SRC-1 and SRC-3), which contain a highly conserved motif (the so-called NR-box) that facilitates interaction with the ligand-dependent activation function (AF-2) of nuclear receptors and amplification of target gene transcription (4) . Interactions between TIF-2 (5) , and its mouse homologue GRIP1 (6) , have been demonstrated for several nuclear receptors (7) .

In the mouse, TIF-2 mRNA and protein are expressed ubiquitously (5 , 8 , 9) , but reports differ regarding its presence in the rat brain (10 , 11) . Targeted ablation of TIF-2 in the mouse is phenotypically marked by impaired gonadal function (12) and altered energy balance and lipid metabolism (13) . Since no other overt functional aberrations have been so far noted in TIF-2–/– mice, compensatory overexpression of the related coactivator SRC-1, implying partial functional redundancy of TIF-2 and SRC-1, has been presumed (14 15 16) .

Given the role of TIF-2 as a GR coactivator, we tested the hypothesis that disruption of TIF-2 would result in attenuated GR signaling in the brain, measurable as alterations in the secretory dynamics of the HPA axis under basal (resting) conditions and following exposure to stressful stimuli. We expected that TIF-2 deficiency would become manifest as a "weakening of the grip" of GR-mediated restraint of the HPA axis, resulting in pituitary-adrenal hyperactivity under quiescent conditions, exaggerated and prolonged secretory response to stress, and increased expression of neuropeptides that trigger HPA activation, e.g., CRH and AVP. As reported here, our starting hypothesis was supported in several respects; however one unexpected but important finding was that TIF-2–/– mice demonstrate symptoms of adrenal insufficiency. The latter result suggests that impaired HPA axis regulation in TIF-2 deficient mice may result from insidious adrenocortical hypofunction rather than failure to amplify GR signaling.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Animals
Animals were generated from a TIF-2+/– male on a C57BL/6N background (Charles River, Germany); five first-generation pairs of TIF-2+/– mice were used for crossbreeding. Randomly cycling females, aged 6–7 mo, from the second generation of null mutants were used in this study, with wild-type (WT) C57BL/6N age-matched females serving as controls. Mutant mice were genotyped as described previously (12) . Polymerase chain reaction (PCR) was done using the primers P1 [CTG CAC GGT GCC automatic gain control (AGC) AAA GC), P2 (GAC CAG GGC TTG CTC AGA AC) and P3 (CCC CTG GAT TGT TCC AAA GG]. The WT and –/– alleles resulted in products of 512 and 298 bp, respectively.

Animals were housed under standard conditions (24°C; 60–70% relative humidity, 12h light/dark with lights on at 06:00; ad libitum access to chow pellets and water). All procedures complied with NIH guidelines on laboratory animal use and were approved by the local ethical board.

Stress protocol
Peak and nadir basal CORT levels were determined in tail vein blood (collected within 30 s of removal from home cage) at 18:00 and 06:00 h.

The first experiment, which examined the endocrine response to short-term acute stress, started immediately after the morning blood collection. Stress procedures encompassed transfer to the procedure room, placement into a glass container (diameter 15 cm), and exposure to low-frequency vibration (ca. 25 Hz, delivered by a Vortex) and loud music (80–90 dB) for 1 min, before returning to the home cage. Blood samples were taken to measure stress-induced (30 min) and recovery-phase (120 min) levels of CORT. One week later, animals were randomly assigned to subgroups for tissue collection. Between 08:00 and 11:00 h one subgroup was killed immediately on removal from the home cage, and the other 30 min after exposure to the above-described stress procedure. Tissue specimens were either snap-frozen or immersion-fixed in PBS/p-formaldehyde for subsequent analysis.

A different set of animals from the third cross-bred generation was used for examination of responses to prolonged physical stress. The mice were immobilized in plastic restrainers for 4 h between 08:00 and 12:00 h. Blood from tail vein incisions was collected for CORT determination 15, 120, and 240 min after the beginning of immobilization.

Hormone assays
Serum CORT was measured by RIA (MP Biomedicals, Orangeburg, NY, USA). Pituitary ACTH contents were determined by RIA (DSL, Webster, TX, USA) in 0.1 N acetic acid extracts, and results were normalized to tissue protein levels; the antibody (Ab) had 100% cross-reaction for the species-invariable, bioactive amino acid fragment ACTH (1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24) . Coefficients of variation of the CORT and ACTH assays were 12 and 10%, respectively.

Nucleic acid probes and primers
AVP transcripts were detected with a 48-mer antisense probe (17) complementary to bases 1493–1540 of the murine vasopressin gene (M_88345). The 40-mer probe for 3ß-HSD mRNA corresponded to bases 531–570 of the murine gene sequence (M_77015), with one mismatch to a rat-specific probe (18) . Oligonucleotides were labeled with [35S]-dATP (NEN, Boston, MA, USA) using terminal deoxynucleotidyl transferase (TdT) (Invitrogen, Karlsruhe, Germany). Labeled ribonucleotide probes for the detection of CRH-, GR-, SRC-1, and StAR protein-encoding transcripts were produced from linearized plasmids using in vitro-transcription kits with T7, T3, and Sp6 RNA polymerases (Promega, Madison, WI, USA) and [35S]-dUTP. The CRH cDNA template was a 760 bp fragment comprising bases 260–1020 of the mouse CRH gene (AY_128673). The GR template included bases 81–528 of the rat GR mRNA sequence (M_14053). A 622 bp fragment corresponding to bases 1121–1743 of the human SRC-1 (U_90661) was used for SRC-1 mRNA detection. The probe for StAR protein transcripts was amplified by PCR from the clone IRAKp961L18177Q (RZPD, Berlin, Germany) using the primers 5'-ATGTTCCTCGCTACGTTCAAG-3' and 5'-CCAAGCGAAACACCTTGCC-3'. The resulting fragment of 364 bp, corresponding to bases 57–420 of the murine StAR protein sequence (NM_011485), was cloned into pTOPO and, on sequence verification and linearization with HindIII and XbaI, used for the generation of antisense and sense probes, respectively. The plasmid encoding 246 bp (bases 1914–2160) of the 3'UTR of the mouse SF-1 gene (NM_139051) was linearized with HindIII and EcoRI, for transcription of antisense and sense probe, respectively.

In situ hybridization histochemistry
Transcripts encoding AVP and CRH were quantified in the rostral extension of the PVN (bregma –0.75 to –0.85); those encoding GR were measured in the dorsal hippocampus (bregma –1.70 to –1.90) and the PVN (19) . Expression of SRC-1 mRNA was examined in the hippocampus. Coronal 10-µm-thick brain cryosections were hybridized with oligo- and ribonucleotide probes according to established protocols (20 , 21) . Autoradiographs were generated by film exposure (BioMax MR; Kodak, Rochester, NY, USA).

Semiquantitative densitometric analysis of brain autoradiograhs was performed using the NIH software Scion Image Beta 4.2.0. AVP transcript signal intensity was measured in fixed-size squares within the ventromedial compartment of the PVN, centered over its parvocellular division. CRH transcript densities were evaluated within the entire PVN. GR hybridization signals were measured in the pyramidal cell layer of the CA1–2 fields of the hippocampus and in the PVN. SRC-1 mRNA transcript intensities were compared in the granule cell layer of dentate gyrus (22) .

Bilateral optical density (OD) measurements were made in two sections per animal. Individual averaged transmittance levels were converted to specific radioactivity by third-order polynomial equations generated from coexposed 14C standards (ARC; St. Louis, MO, USA).

Detection of transcripts encoding SF-1, StAR protein, and 3ß-HSD in the adrenal cortex was performed in 5 µm sections through the equatorial plane of paraffin-embedded glands. Following deparaffinization (xylene), sections were permeabilized, delipidated, hybridized, and stringently washed (40 , 41) . Slides were exposed to photographic emulsion (NTB; Kodak, Rochester, NY, USA) for 3 d and lightly counterstained with cresyl violet.

The software package Image Pro Plus (Media Cybrnetics, Silver Spring, MD, USA) was used for the quantification of transcripts in adrenal sections. In each section, two rectangular frames of preset size were placed within the microscopic image of zona fasciculata at a magnification of x400. Identical illumination conditions and size thresholds for inclusion/exclusion of silver grains were applied to all sections. The number of signal-positive particles was subsequently related to the cell counts measured in each frame. Four measurements were averaged to produce individual means.

Reverse-transcriptase polymerase chain reaction (RT-PCR) detection of DAX-1
RNA was isolated using the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany); integrity was confirmed with the Agilent System (Agilent Technologies, Palo Alto, CA, USA), according to the manufacturer’s protocol. From each individual extract, 500 ng were reverse-transcribed into cDNA using the Superscript III Platinum Kit (Invitrogen, Karlsruhe, Germany). For real-time PCR, cDNA (50 ng) was amplified using the TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA, USA) according to the protocol of the supplier. The oligonucleotide probe sets for mouse DAX-1 (Mm 00431729_m1) and ß-actin (Mm 00607939_s1) were purchased from Applied Biosystems. Normalization to ß-actin and calculation of relative DAX-1 expression was done by the {Delta}Ct method (Applied Biosystems).

Adrenocortical morphometry
Cellular densities in the adrenocortical zona fasciculata were determined in hematoxylin-eosin-stained paraffin sections through the equatorial plane. Cell nuclei were counted using the Image Pro Plus software within fixed-size rectangular frames of 120 x 120 µm, positioned in two diametrically opposed sites of zona fasciculata. The threshold discrimination tool was uniformly applied to ensure recognition of only nuclear staining as positive signal. For each animal, counts from four frames placed at the opposite poles two sections were averaged.

Statistics
Numerical data (shown as mean ± SEM) were analyzed by 1-way ANOVA and Tukey’s test, where appropriate. Key ANOVA parameters (F-values, degrees of freedom) are given in the description of results. The level of significance was preset at P < 0.05.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
No conspicuous gross phenotypic features were observed in TIF-2–/– mice (up to 1 yr old), except that the males have easily discernible reduced testicular volumes. At autopsy, the ovaries of TIF-2–/– mice were significantly smaller (8.5±0.4 mg) than those of WT and heterozygous TIF-2+/– (12.2±0.8 and 11.0±0.8 mg, respectively). Adrenal and uterine weights in TIF-2–/– mice were lower but not significantly different from those observed in WT mice.

TIF-2 deletion is associated with increased neural drive on the HPA axis
Expression levels of hypothalamic CRH and AVP, and pituitary ACTH content in TIF-2 deficient animals indicated hyperactivation of the hypothalamo-pituitary unit. Under basal (stress-free) conditions, the levels of the mRNAs encoding CRH and AVP in the hypothalamic paraventricular nucleus (PVN) were significantly elevated in TIF-2/ mice, as compared to WT and TIF-2+/– (Fig. 1 ; F2,10=12.19 and 10.66; P=0.004 and 0.003, respectively). CRH and AVP mRNA transcript numbers were rapidly up-regulated by stress in WT and TIF-2+/–, but not TIF-2–/–, mice (Fig. 1 ; F2,11=5.71 and 4.48; P=0.02 and 0.035, respectively). Pituitary ACTH content in TIF-2–/– mice was significantly higher than that measured in WT and TIF-2+/– animals (Fig. 2 ; F2,10=8.55; P=0.007). Stress exposure failed to significantly change pituitary ACTH content in any genotype.


Figure 1
View larger version (15K):
[in this window]
[in a new window]

 
Figure 1. Altered expression of HPA axis-related neuropeptides in TIF-2 mutant mice. Note that although CRH and AVP expression was increased in the hypothalamic PVN of TIF-2 null mutants, the expression of the mRNAs encoding these peptides was not influenced by exposure to stress. Asterisks indicate significant differences as compared to WT mice; daggers denote significant changes 30 min after stress; n = 3–5 mice/group.


Figure 2
View larger version (11K):
[in this window]
[in a new window]

 
Figure 2. TIF-2 deletion results in increased ACTH production. Pituitary ACTH content is elevated in TIF-2–/– animals; stress-induced changes were not observed in any genotype. Asterisks mark significant differences to WT mice; n = 3–5 mice/group.

Genotype-associated changes in the expression of GR in the brain complemented the symptoms of HPA hyperactivity. Significantly decreased GR mRNA levels were observed in the CA1–2 subfield of the hippocampus of homo- and heterozygous TIF-2 deficient mice (Fig. 3 ; F2,8=58.47; P<0.001), and a similar, albeit nonsignificant, trend was seen in the hypothalamic PVN. Expression of SRC-1 mRNA was seen throughout the hippocampal formation, without any significant genotype-related differences (Fig. 3) .


Figure 3
View larger version (13K):
[in this window]
[in a new window]

 
Figure 3. Reduced expression of glucocorticoid receptors in the brain of TIF-2 mutants. Basal levels of GR mRNA in the hippocampal area CA1–2 are decreased in TIF2+/– and TIF-2–/– animals, with a similar pattern being observed in the hypothalamic PVN. Lack of significant differences in SRC-1 mRNA in the dentate gyrus of the hippocampus failed to support the notion of compensatory overexpression in TIF-2–/– mice. Asterisks denote significant differences vs. WT mice; n = 3–5 mice/group.

Impaired adrenocortical output in TIF2–/– mice
Surprisingly, basal (morning) serum corticosterone (CORT) levels in TIF-2–/– mice were significantly lower than those in TIF-2+/– and WT animals (Fig. 4 ; F2,22=5.82, P=0.01). At the diurnal zenith of adrenocortical activity CORT secretion was similar in all groups (140±22, 139±21 and 137±20 ng/ml). Exposure to a brief emotional stress significantly increased CORT levels over baseline in all genotypes; however, the secretory response measured 30 min post-stress was significantly attenuated in TIF-2–/– animals, as compared to that in TIF-2+/– and WT mice (Fig. 4 ; F2,22=17.35; P<0.001). Although similar trends were observed in CORT levels measured after 120 min, they were not statistically significant.


Figure 4
View larger version (17K):
[in this window]
[in a new window]

 
Figure 4. Corticosteroid secretion is impaired in TIF-2 mutants. TIF-2 deficiency is associated with decreased basal corticosterone levels and attenuated early secretory responses to both short-lasting (n=7 mice/group) and prolonged (n=6 mice/group) stress. Asterisks indicate significant differences from levels measured in WT mice at the corresponding time point.

An independent experiment corroborated the observation of decreased adrenocortical output in TIF-2-deficiency during the initial phase of the stress response. CORT levels, measured during protracted immobilization stress for 4 h, were significantly lower in TIF-2–/– and heterozygous animals at 15 min (Fig. 4 ; F2,12=8.90; P<0.004), but these differences between genotypes became less pronounced with increasing stress duration. As before, resting (prestress) CORT levels were significantly lower in TIF-2 deficient mice (F2,12=4.35; P<0.04).

Cellular basis for diminished adrenocortical activity in TIF2–/– mice
The discrepancy between signs of increased hypothalamo-pituitary stimulation and modest adrenocortical secretory output prompted us to focus on the adrenal gland. Morphological examination revealed that homo- and heterozygous TIF-2 deficient mice display reduced cell densities in the zona fasciculata of the cortex (Fig. 5 ; F2,24=30.09, P<0.001); these animals showed a loss of the usual columnar organization of cells and an abundance of hypertrophic cells and cells with pyknotic nuclei.


Figure 5
View larger version (49K):
[in this window]
[in a new window]

 
Figure 5. Aberrant adrenocortical histology in TIF-2 ablated mice. Disruption of TIF-2 is associated with decreased cell density and severe cytoachitectural alterations in the zona fasciculata of the adrenal cortex. Asterisks indicate significant differences to WT; n = 4–5 per group.

We next studied several functional descriptors of the adrenal cortex. Adrenal DAX-1 mRNA levels (measured by semiquantitative RT-PCR) were significantly higher in TIF-2–/– vs. WT animals (Fig. 6 ; P<0.009). In contrast, steady-state levels of mRNA coding for the orphan nuclear receptor SF-1 were slightly but significantly decreased in TIF-2–/– vs. WT mice (Fig. 6 ; P<0.04). Neither one of these parameters was altered 30 min after stress (data not shown).


Figure 6
View larger version (11K):
[in this window]
[in a new window]

 
Figure 6. TIF-2 deletion is associated with altered adrenal expression of DAX-1 and SF-1. Increased expression of DAX-1 and decreased abundance of SF-1 in the adrenals of mice homozygous for TIF-2 deficiency. Asterisks denote significant differences to WT; n = 3–5 per group.

Basal mRNA levels of steroidogenic acute regulatory (StAR) protein in the adrenal cortex were similar in WT and TIF-2–/– genotypes. Notably, however, TIF-2–/– mice failed to show an up-regulation of StAR protein mRNA levels 30 min after acute stress; moreover, these animals showed a markedly attenuated increase in this parameter following exposure to prolonged immobilization stress (Fig. 7 ; F5,15=22.24; P<0.001). Similarly, the basal and stress-induced expression of 3ß-hydroxysteroid dehydrogenase (3ß-HSD) in TIF-2–/– mice was significantly lower than that in WT mice (Fig. 7 ; F5,18=28.06; P<0.001).


Figure 7
View larger version (12K):
[in this window]
[in a new window]

 
Figure 7. Expression of StAR protein and 3ß-HSD is compromised by TIF-2 ablation. Induction of StAR protein and 3ß-HSD expression in the adrenal zona fasciculata is attenuated in TIF-2 deficient mice following either brief or prolonged stress. Asterisks show significant differences to WT at corresponding timepoints; n = 3–6 per time point.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
TIF-2 has been shown to amplify GR signaling in a variety of cellular models and contexts (8) , but its physiological relevance in GR-mediated regulation of the HPA axis has not been addressed. Thus, experiments were designed to test the hypothesis that ablation of TIF-2 would disrupt the efficacy of GR-mediated restraint on basal and stress-induced activity at various regulatory levels.

While TIF-2+/– mice showed profiles that largely resembled those found in WT mice, gene dosage proved an important factor in several respects. Under stress-free conditions, hypothalamic levels of the mRNAs encoding CRH and AVP, the two major corticotropin secretagogues, were elevated in TIF-2–/– mice. Predictably, pituitary reserves of ACTH were also significantly increased in TIF-2–/– animals. Given that the CRH and AVP genes, as well as the POMC gene (whose posttranslational products give rise to ACTH), are all subject to negative regulation by GR activation, these results indicate that deletion of TIF-2 leads to disruption of GR negative feedback at the hypothalamic and pituitary levels and, ultimately, hyperactivity of the central compartment of the HPA axis. Reduced GR mRNA expression in the hippocampus and PVN, both of which are crucially involved in the central control of the HPA axis, would also be expected to contribute to reduced restraint of HPA activity in TIF-2–/– mice. Increased basal adrenocortical activity with flattened diurnal oscillations, and exaggerated and prolonged response to stress would be the expected manifestations of impaired glucocorticoid negative feedback in the brain and pituitary of TIF-2–/– mice. However, none of these predictions was fulfilled: despite compelling evidence for hyperactivation of the hypothalamo-pituitary unit, in TIF-2 deficient mice: i) the amplitude of the nocturnal increase in CORT was commensurate with that seen in WT animals; ii) glucocorticoid levels at their diurnal nadir were significantly lower than in other genotypes; and iii) unlike the situation in WT and heterozygous TIF-2 mutants, the CORT response to stress in TIF-2–/– mice was markedly attenuated during the initial phase and generally showed sluggish dynamics. Thus, the most striking feature of aberrant HPA axis regulation in TIF-2 deficient animals is the dissociation between hyperactivity of the hypothalamo-pituitary compartment and symptoms of inadequate adrenocortical secretory output. Accordingly, alterations in the central mechanisms of HPA axis regulation, although indicative of decreased glucocorticoid restraint, cannot be solely ascribed to the lack of TIF-2, a major amplifier of GR transcriptional signaling (5 6 7 8 9) .

The patterns of GR expression in the hippocampus of TIF-2–/– mice illustrate the confounds associated with interpretation of our studies in terms of TIF-2 as a GR coactivator only. Based on the prevailing view (23 , 24) , homologous down-regulation by CORT excess would be the most plausible explanation of decreased GR expression in the hippocampus. However, this is hardly tenable in view of the absence of symptoms of hypercorticalism in TIF-2 deficient mice under either basal or stressful conditions. Our data also do not support previous suggestions that another GR coactivator, SRC-1, may compensate for TIF-2 deficiency (14 15 16) , despite recent evidence that SRC-1 is involved in HPA axis regulation (25) . Thus, as the importance of coregulators in the control of nuclear receptor expression has not been comprehensively elucidated, we considered it prudent to assume that TIF-2 may be involved in the control of GR expression through mechanisms that are independent of its role as a nuclear receptor coregulator.

Deficits in the endocrine response to stress could also originate from impaired hypothalamo-pituitary neurohumoral communication. Unlike WT and TIF-2+/– mice, CRH and AVP expression in TIF-2 null mutants was refractory to brief stressful stimuli. Accordingly, the inability of TIF-2–/– mice to up-regulate CRH and AVP expression in response to a stressor may be ascribed to either limited synthetic capacity of the (already hyperactive) hypothalamic neurons or autologous desensitization of pituitary CRH and AVP receptors (26 , 27) , ultimately resulting in impaired translation of the peptidergic stimuli into adequate pituitary-adrenal secretory responses. This aspect of the neuroendocrine response of TIF-2–/– mice resembles the situation observed in adrenalectomized animals; the latter display increased basal and blunted stress-induced expression of ACTH, CRH, and AVP (28 29 30) .

In light of the various above-mentioned findings that suggested deficits at the distal end of the HPA cascade, we investigated some key aspects of adrenocortical morphology and function. Previous studies described anomalous gonadal developmental and impaired reproductive function in TIF-2 deficient mice (12 , 15) . In the present study, we observed that TIF-2 null mutants tend to have smaller adrenal glands, hinting at possible defects in adrenal organogenesis. Both TIF-2–/– and TIF-2+/– mice were found to have structural abnormalities in the glucorticoid-synthesizing zona fasciculata of the adrenal cortex, namely, reduced cell densities and loss of the columnar organization. These characteristics, together with the sporadic occurrence of pyknotic cells in the zona fasciculata, are reminiscent of the histological changes described in congenital adrenal hypoplasia (31) . The view that adrenocortical development and function may be disrupted in TIF-2 null mutants was bolstered by our observations of high levels of DAX-1 expression in the adrenal cortex and, concomitantly, reduced abundance of SF-1. These two transcription factors have been shown to act in a reciprocal manner in the coordination of adrenocortical growth, maturation and steroidogenesis (32 33 34) ; their expression profiles in TIF-2–/– mice indicate that aberrant adrenocortical development belies the reduced steroidogenic capacity in these animals.

Since TIF-2 can coactivate SF-1 (35 , 36) , it seems plausible that disruption of TIF-2 affects SF-1 dependent gene transcription which, in turn, impairs corticosteroidogenesis. Indeed, StAR protein and 3ß-HSD, which are positively regulated by SF-1 and crucially involved in glucocorticoid synthesis (37 , 38) , were poorly induced in the TIF-2 null mutants. Interestingly, TIF-2 null mutants and SF-1-haploinsufficient mice show highly similar phenotypes in terms of adrenal histology and stress responses (39) .

In summary, our data demonstrate that signs of a "loss of grip" of glucocorticoid feedback in the HPA axis in TIF-2 deficient mice are not likely to be solely ascribed to disrupted GR signal amplification. Preliminary data from ongoing experiments addressing the responsiveness of TIF-2 deficient mice to exogenous glucocorticoids are not indicative of glucocorticoid resistance in these animals. Symptoms of structural and functional impairment in the adrenal cortex of TIF-2 mutants suggest that alterations in the neural control of the HPA axis occur secondarily to insidious adrenocortical insufficiency. In view of earlier and recent demonstrations of GR expression in the fetal (40) and adult adrenal cortex (41) , and potentiation of corticotropin effects in adrenocortical cells by glucocorticoids (42) , the intriguing question opened by these observations is whether the lack of TIF-2, which results in poor amplification of trophic GR signaling, may be responsible for compromised adrenocortical development and steroidogenic capacity. Meanwhile, the association between TIF-2 deletion and adrenal dysfunction (this study) and hypogonadism (12 , 15) strongly suggest a novel role for this nuclear receptor coregulator in the morphogenesis and function of steroid-producing glands.


   ACKNOWLEDGMENTS
 
This study was supported by an EC (FP6) collaborative grant (QLG3-CT-2000–00844). We appreciate the technical assistance of A. Fishbach, H. Lück, S. Thalheim, S. Herrmann, and J. Waldherr. The generous provision of expression plasmids by Drs. J. Herman (Cincinnati, OH, USA), K. Yamamoto (San Francisco, CA, USA), M.-J. Tsai (Houston, TX, USA) and K. Parker (Dallas, TX, USA) is gratefully acknowledged.

Received for publication July 24, 2006. Accepted for publication August 21, 2006.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Chrousos, G. P., Gold, P. W. (1992) The concept of stress and stress system disorders. Overview of physiological and behavioral homeostasis. JAMA 267,1244-1252[Abstract]
  2. Sapolsky, R.M., Romero, L. M., Munck, A. U. (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory and preparative actions. Endocr. Rev. 21,55-89[Abstract/Free Full Text]
  3. De Kloet, E.R., Joels, M., Holsboer, F. (2005) Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6,463-475[CrossRef][Medline]
  4. Glass, C. K., Rosenfeld, M. G. (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14,121-141[Free Full Text]
  5. Voegel, J.J., Heine, M.J., Zechel, C., Chambon, P., Gronemeyer, H. (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15,3667-3675[Medline]
  6. Hong, H., Kohli, K., Trivedi, A., Johnson, D. L., Stallcup, M. R. (1996) GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. U. S. A. 93,4948-4952[Abstract/Free Full Text]
  7. Leo, C., Chen, J. D. (2000) The SRC family of nuclear receptor coactivators. Gene 245,1-11[CrossRef][Medline]
  8. Hong, H., Kohli, K., Garabedian, M. J., Stallcup, M. R. (1997) GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid and vitamin D receptors. Mol. Cell. Biology. 17,2735-2744[Abstract]
  9. Puustinen, R., Sarvilinna, N., Manninen, T., Tuohimaa, P., Ylikomi, T. (2001) Localization of glucocorticoid receptor interacting protein 1 in murine tissues using two novel polyclonal antibodies. Eur. J. Endocrinol. 145,323-333[Abstract]
  10. Meijer, O.C., Steenbergen, P. J., de Kloet, E. R. (2000) Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 141,2192-2199[Abstract/Free Full Text]
  11. Martinez de Arrieta, C., Koibuchi, N., Chin, W. W. (2000) Coactivator and corepressor gene expression in the rat cerebellum during postnatal development and the effect of altered thyroid status. Endocrinology 141,1693-1698[Abstract/Free Full Text]
  12. Gehin, M., Mark, M., Dennefeld, C., Dierich, A., Gronemeyer, H., Chambon, P. (2002) The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol. Cell. Biology. 22,5923-5937[Abstract/Free Full Text]
  13. Picard, F., Gehin, M., Annicotte, J., Rocchi, S., Champy, M.F., O’Malley, B.W., Chambon, P., Auwerx, J. (2002) SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111,931-941[CrossRef][Medline]
  14. Xu, J., Qiu, Y., DeMayo, F.J., Tsai, S.Y., Tsai, M. J., O’Malley, B. W. (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279,1922-1925[Abstract/Free Full Text]
  15. Xu, J., Li, Q. (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 17,1681-1692[Abstract/Free Full Text]
  16. Mark, M., Yoshida-Komiya, H., Gehin, M., Liao, L., Tsai, M.J., O’Malley, B.W., Chambon, P., Xu, J. (2004) Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction. Proc. Natl. Acad. Sci. U. S. A. 101,4453-4458[Abstract/Free Full Text]
  17. Nishi, R., Ueta, Y., Serino, R., Nomura, M., Yamamoto, Y., Shibuya, I., Koizumi, K., Yamashita, H. (1999) Increase of vasopressin mRNA in the hypothalamus of inbred polydipsic mice. Brain Res. Bull. 50,47-51[CrossRef][Medline]
  18. Coirini, H., Gouézou, M., Liere, P., Delespierre, B., Pianos, A., Eychenne, B., Schumacher, M., Guennoun, R. (2002) 3ß-Hydroxasteroid dehydrogenase expression in rat spinal cord. Neuroscience 113,883-891[CrossRef][Medline]
  19. Franklin, K.B.J., Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates Academic Press San Diego, CA, U. S. A..
  20. Brady, L.S., Smith, M., Gold, P. W., Herkenham, M. (1990) Altered expression of hypothalamic neuropeptide mRNA in food-restricted and food-deprived rats. Neuroendocrinology 52,441-447[Medline]
  21. Whitfield, H.J., jr, Brady, L.S., Smith, M.A., Mamalaki, E., Fox, R., Herkenham, M. (1990) Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: A detailed protocol. Cell. Mol. Neurobiol. 10,145-157[CrossRef][Medline]
  22. Mitev, Y.A., Wolf, S.S., Almeida, O. F. X., Patchev, V. K. (2003) Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC-1 as discriminative amplifier of estrogen signaling in the rat brain. FASEB J. 17,518-519[Abstract/Free Full Text]
  23. Patchev, V.K., Brady, L.S., Karl, M., Chrousos, G. P. (1994) Regulation of HSP90 and corticosteroid receptor mRNA by corticosterone levels in vivo. Mol. Cell. Endocrinol. 103,57-64[CrossRef][Medline]
  24. Herman, J. P., Spencer, R. (1998) Regulation of hippocampal glucocorticoid receptor gene transcription and protein expression in vivo. J. Neurosci. 18,7462-7473[Abstract/Free Full Text]
  25. Winnay, J.N., Xu, J., O’Malley, B. W., Hammer, G. D. (2006) Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology 147,1322-1332[Abstract/Free Full Text]
  26. Aguilera, G., Rabadan-Diehl, C. (2000) Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat. Exp. Physiol. 85,19S-26S[Abstract]
  27. Aguilera, G., Rabadan-Diehl, C., Nikodemova, M. (2001) Regulation of pituitary corticotropin releasing hormone receptors. Peptides 22,769-774[CrossRef][Medline]
  28. Akana, S. F., Dallman, M. F. (1997) Chronic cold in adrenalectomized, corticosterone (B)-treated rats: Facilitated corticotropin responses to acute restraint emerge as B increases. Endocrinology 138,3249-3258[Abstract/Free Full Text]
  29. Marti, O., Harbuz, M.S., Andrés, R., Lightman, S. L., Armario, A. (1999) Activation of the hypothalamic-pituitary axis in adrenalectomised rats: potentiation by chronic stress. Brain Res. 821,1-7[CrossRef][Medline]
  30. Weidenfeld, J., Feldman, S. (2000) Effects of adrenalectomy and corticosterone replacement on the hypothalamic-pituitary response to neural stimuli. Brain Res. 877,73-78[CrossRef][Medline]
  31. Weiss, L., Mellinger, R. C. (1970) Congenital adrenal hypoplasia—an X-linked disease. J. Med. Genet. 7,27-32[Medline]
  32. Babu, P.S., Bavers, D.L., Beuschlein, F., Shah, S., Jeffs, B., Jameson, J. L., Hammer, G. D. (2002) Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 143,665-673[Abstract/Free Full Text]
  33. Lalli, E., Sassone-Corsi, P. (2003) DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol. Endocrinol. 17,1445-1453[Abstract/Free Full Text]
  34. Hammer, G.D., Parker, K. L., Schimmer, B. P. (2005) Transcriptional regulation of adrenocortical development. Endocrinology 146,1018-1024[Abstract/Free Full Text]
  35. Hammer, G.D., Krylova, I., Zhang, Y., Darimont, B.D., Simpson, K., Weigel, N. L., Ingraham, H. A. (1999) Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress. Molecular Cell 3,521-526[CrossRef][Medline]
  36. Børud, B., Hoang, T., Bakke, M., Jacob, A.L., Lund, J., Mellgren, G. (2002) The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol. Endocrinol. 16,757-773[Abstract/Free Full Text]
  37. Parker, K. L., Schimmer, B. P. (1997) Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr. Rev. 18,361-377[Abstract/Free Full Text]
  38. Sandhoff, T.W., Hales, D.B., Hales, K. H., McLean, M. P. (1998) Transcriptional regulation of the rat steroidogenic acute regulatory protein gene by steroidogenic factor 1. Endocrinology 139,4820-4831[Abstract/Free Full Text]
  39. Bland, M., Jamieson, C.A.M., Akana, S.F., Bornstein, S.R., Eisenhofer, G., Dallman, M. F., Ingraham, H. A. (2000) Haploinsufficiency of steroidogenic factor-1 in mice disrupts adrenal development leading to an impaired stress response. Proc. Natl. Acad. Sci. U. S. A. 97,14488-14493[Abstract/Free Full Text]
  40. Condon, J., Gosden, C., Gardener, D., Nickson, P., Hewison, M., Howie, A. J., Stewart, P. M. (1998) Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J. Clin. Endocrinol. Metab. 83,4490-4497[Abstract/Free Full Text]
  41. Paust, H.J., Loeper, S., Else, T., Bamberger, A.M., Papadopoulos, G., Pankoke, D., Saeger, W., Bamberger, C. M. (2006) Expression of glucocorticoid receptor in the human adrenal cortex. Exp. Clin. Endocrinol. Diabetes. 114,6-10[CrossRef][Medline]
  42. Picard-Hagen, N., Penhoat, A., Hue, D., Jaillard, C., Durand, P. (1997) Glucocorticoids enhance corticotropin receptor mRNA levels in ovine adrenocortical cells. J. Mol. Endocrinol. 19,29-36[Abstract]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-6952comv1
21/1/231    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patchev, A. V.
Right arrow Articles by Almeida, O. F. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patchev, A. V.
Right arrow Articles by Almeida, O. F. X.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS